Dáil Éireann Debate, Thursday - 23 March 2017
141. Deputy Charlie McConalogue asked the Minister for Health the status of the ongoing negotiations between the HSE and manufacturers regarding the drug Savitex; if he will ensure that the drug will be made available to persons; and if he will make a statement on the matter. [14590/17]
View answerThe HSE has statutory responsibility for decisions on the reimbursement of approved products in Ireland and suppliers of such products must apply to the HSE for reimbursement approval.
I am advised that, following receipt of an application from the supplier for the inclusion of Sativex on the High Tech Scheme, the HSE assessed the medicine in line with their statutory responsibility. The HSE issued the manufacturers with notice of its intention not to reimburse. It is open to the supplier to make a new application for this product, in the context of the previous findings.
